Memantine Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69680-161 -
Package NDC
69680-161-30 -
Application number
ANDA213985 -
SPL ID
64b8e27d-8127-4df2-a089-dbcd873c4e5e -
SPL set ID
0c7fd6ab-2ce5-4110-b6e6-9103c8da0765 -
UNII
JY0WD0UA60 -
RxCUI
996594 -
RxCUI
996603 -
RxCUI
996609 -
RxCUI
996615
What the source publishes
- Labeler
- Vitruvias Therapeutics, Inc.
- Active ingredients
- memantine hydrochloride
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Memantine Hydrochloride",
"splId": "64b8e27d-8127-4df2-a089-dbcd873c4e5e",
"labels": [
{
"setId": "0c7fd6ab-2ce5-4110-b6e6-9103c8da0765",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c7fd6ab-2ce5-4110-b6e6-9103c8da0765",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c7fd6ab-2ce5-4110-b6e6-9103c8da0765"
}
],
"routes": [
"ORAL"
],
"labeler": "Vitruvias Therapeutics, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-161-30)",
"package_ndc": "69680-161-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20231215"
}
],
"productId": "69680-161_64b8e27d-8127-4df2-a089-dbcd873c4e5e",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "69680-161",
"deaSchedule": null,
"genericName": "memantine hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MEMANTINE HYDROCHLORIDE",
"strength": "7 mg/1"
}
],
"applicationNumber": "ANDA213985",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20231215",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0369680163307",
"0369680162300",
"0369680164304",
"0369680161303"
],
"unii": [
"JY0WD0UA60"
],
"rxcui": [
"996594",
"996603",
"996609",
"996615"
],
"spl_set_id": [
"0c7fd6ab-2ce5-4110-b6e6-9103c8da0765"
],
"manufacturer_name": [
"Vitruvias Therapeutics, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69680-161_64b8e27d-8127-4df2-a089-dbcd873c4e5e"